PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
Author:
Publisher
Elsevier BV
Subject
Cancer Research
Reference69 articles.
1. PIK3CA in cancer: the past 30 years;Arafeh;Semin. Cancer Biol.,2019
2. Genetic deregulation of the PIK3CA oncogene in oral cancer;Murugan;Cancer Lett.,2013
3. PTEN: an intercellular peacekeeper?;Leslie;Sci. Signal.,2012
4. AKT in cancer: new molecular insights and advances in drug development;Mundi;Br. J. Clin. Pharmacol.,2016
5. Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer;Miller;J. Clin. Oncol.,2011
Cited by 600 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prediction of the Molecular Mechanism of Corni Fructus-Epimedii Folium- Rehmanniae Radix Praeparata in the Treatment of Postmenopausal Osteoporosis based on Network Pharmacology and Molecular Docking;Current Computer-Aided Drug Design;2024-04
2. B7–H1 agonists suppress the PI3K/AKT/mtor pathway by degrading p110γ and independently induce cell death;Cancer Letters;2024-03
3. Exploring targets and related mechanisms of Scutellaria baicalensis for treating non-small cell lung cancer based on network pharmacology;Pharmacological Research - Modern Chinese Medicine;2024-02
4. Systematic pan-cancer analysis of RNF186 with potential implications in progression and prognosis in human cancer;Life Sciences;2024-02
5. A review of photobiomodulation on PI3K/AKT/mTOR in wound healing;Journal of Photochemistry and Photobiology;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前全球学者库共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3